A platform for the fast development of thermostable lyophilized mRNA lipid nanoparticle (LNP) vaccines

07 February 2024 → 31 December 2026
Funding by bilateral agreement (private and foundations)
Research disciplines
  • Medical and health sciences
    • Vaccinology
    • Pharmaceutical analysis and quality assurance not elsewhere classified
    • Pharmaceutical technology
    • Physical pharmacy
  • Engineering and technology
    • Manufacturing processes, methods and technologies
mRNA vaccine lipid nanoparticle continuous freezedrying
Project description

Within this project an innovative spinfreeze technology will be used to enhance the thermostability of mRNA vaccines. An analytical toolbox will be developed to analyse and understand the impact of the freeze drying process on the mRNA vaccines.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Union nor the authority can be held responsible for them.